Boskabady Mohammad Hossein, Eslamizade Mohamad Javad, Tabatabaei Abas, Nemati Habib, Mansouri Fariba
Department of Physiology and Pharmacological Research Centre of Medical Plants, Mashhad, Irán.
Arch Bronconeumol. 2010 May;46(5):215-22. doi: 10.1016/j.arbres.2010.02.008. Epub 2010 Apr 18.
The effect of an inhaled corticosteroid, fluticasone propionate (FP) lung inflammation of sensitized guinea pig was examined.
Four groups of guinea pigs (n=8) were sensitized (S) with ovalbumin (OA). Control group was given similar solutions without OA. One S group was treated with inhaled 250 microg inhaled FP twice/day during, other group after sensitization for 18 days and two groups were treated with placebo, one during, and the other after sensitization. One day after the last treatment, tracheal responses of all animal groups to methacholine and OA were examined. Total and differential white blood cell (WBC) counts of lung lavage and lung pathology were also examined.
Tracheal responsiveness to both methacholine and OA and WBC of both placebo groups were significantly higher than those of control group (P<0.001 for all cases). The lungs of placebo groups showed variable pathological changes (non significant to P<0.001) compared to control group. Tracheal responsiveness in two treated groups with FP to both methacholine and OA were significantly decreased compared to placebo groups (P<0.01 to P<0.001). Treatment with FP leads to improvement in total (P<0.001) and differential WBC counts (non significant to P<0.001) as well as mucosal detachment (P<0.001), but not other pathological changes.
These results showed a protective effect of FP on tracheal responsiveness and lung inflammation. In addition, this study showed that treatment with inhaled fluticasone propionate, during sensitization (development of inflammation and pathological changes) was more effective than after sensitization (establishment of inflammation and pathological changes).
研究吸入性皮质类固醇丙酸氟替卡松(FP)对致敏豚鼠肺部炎症的影响。
四组豚鼠(每组n = 8)用卵清蛋白(OA)致敏。对照组给予不含OA的类似溶液。一组致敏组每天两次吸入250微克FP,持续18天,另一组在致敏后进行治疗,两组给予安慰剂,一组在致敏期间,另一组在致敏后。最后一次治疗后一天,检测所有动物组对乙酰甲胆碱和OA的气管反应。还检测了肺灌洗的白细胞总数和分类计数以及肺部病理学情况。
两个安慰剂组对乙酰甲胆碱和OA的气管反应性以及白细胞计数均显著高于对照组(所有情况P < 0.001)。与对照组相比,安慰剂组的肺部显示出不同程度的病理变化(从无显著性差异到P < 0.001)。与安慰剂组相比,两组接受FP治疗的组对乙酰甲胆碱和OA的气管反应性均显著降低(P < 0.01至P < 0.001)。FP治疗可使白细胞总数(P < 0.001)和分类计数(从无显著性差异到P < 0.001)以及黏膜脱落情况(P < 0.001)得到改善,但对其他病理变化无影响。
这些结果表明FP对气管反应性和肺部炎症具有保护作用。此外,本研究表明,在致敏期间(炎症和病理变化发展阶段)吸入丙酸氟替卡松治疗比致敏后(炎症和病理变化确立阶段)更有效。